Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is one of the most aggressive renal cell carcinomas. It predominantly afflicts young adults and adolescents with sickle cell trait and other sickle hemoglobinopathies, and is refractory to targeted and anti-angiogenic therapies used in patients with clear-cell renal c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Genitourin Cancer
Autori principali: Msaouel, Pavlos, Hong, Andrew L., Mullen, Elizabeth A., Atkins, Michael B., Walker, Cheryl Lyn, Lee, Chung-Han, Carden, Marcus A., Genovese, Giannicola, Linehan, W. Marston, Rao, Priya, Merino, Maria J., Grodman, Howard, Dome, Jeffrey S., Fernandez, Conrad V., Geller, James I., Apolo, Andrea B., Daw, Najat C., Hodges, H. Courtney, Moxey-Mims, Marva, Wei, Darmood, Bottaro, Donald P., Staehler, Michael, Karam, Jose A., Rathmell, W. Kimryn, Tannir, Nizar M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348017/
https://ncbi.nlm.nih.gov/pubmed/30287223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2018.09.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi